2cureX AB (2QE) Stock Statistics & Valuation Metrics

2cureX AB has a market cap or net worth of €7.86M. The enterprise value is ―.

2cureX AB has 17,602,917 shares outstanding. The number of shares has decreased by -2.65% in one year.

2cureX AB’s return on equity (ROE) is ― and return on invested capital (ROIC) is ―.

The current PE Ratio of 2cureX AB is -1.09. 2cureX AB’s PEG ratio is -0.02.

In the last 12 months, 2cureX AB had revenue of 155.00K and earned -32.52M in profits. Earnings per share was -1.85.

In the last 12 months, operating cash flow was -22.59M and capital expenditures -17.00K, giving a free cash flow of -22.61M billion.

2cureX AB pays an annual dividend of ―, resulting in a dividend yield of ―

2cureX AB upcoming earnings date is May 29, 2025, TBA Not Confirmed.

2cureX AB as a current ratio of 3.75, with Debt / Equity ratio of 0.00%

In the past 12 months, 2cureX AB has paid -4.63M in taxes.

2cureX AB EV to EBITDA ratio is ―, with an EV/FCF ratio of ―.

2cureX AB has €3.13M in cash and marketable securities with kr0.00 in debt, giving a net cash position of -€3.13M billion.

Gross margin is -1012.38%, with operating margin of -23460.00%, and net profit margin of -20979.35%.

The average price target for 2cureX AB is ―, which is 11.43% higher than the current price. The consensus rating is ―